Literature DB >> 19282565

Prognostic significance of bone marrow histology in multiple myeloma.

R Subramanian1, D Basu, T K Dutta.   

Abstract

BACKGROUND: Bone marrow examination continues to be the cornerstone for establishing the diagnosis of multiple myeloma in association with other clinical and laboratory parameters. Plasma cell morphology has significant correlation with clinical stage and survival. AIMS: To note the bone marrow histology in detail in multiple myeloma and to correlate it with clinical stage and survival. METHODS AND MATERIAL: Fifty-five cases of multiple myeloma diagnosed between January 2001 and December 2006, who had a bone marrow aspiration and biopsy done at the time of diagnosis were included in the present study. STATISTICAL ANALYSIS: SPSS software version 13.0 was used. Clinical stage and plasma cell morphology were correlated using chi square test and Spearman's correlation coefficient. Survival analysis was done using the Kaplan-Meier method.
RESULTS: Seventy-six percent patients were in clinical stage III, 17% and 7% were in stage II and I respectively. The clinical stage correlated significantly with plasma cell morphology, percentage of plasma cell infiltration and pattern of infiltration. Plasma cell morphology correlated significantly with bone marrow parameters like percentage infiltrate, pattern of infiltration, degree of fibrosis and mitotic activity. Patients in advanced clinical stage,> 50% plasma cells in the marrow, diffuse pattern of infiltration, high mitosis and increased fibrosis had a shorter median survival than patients with favorable features.
CONCLUSIONS: It is recommended that the bone marrow histology be studied in detail in multiple myeloma at diagnosis since it correlates well with the clinical stage and offers useful prognostic information.

Entities:  

Mesh:

Year:  2009        PMID: 19282565     DOI: 10.4103/0019-509x.48594

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  8 in total

1.  The value of FDG PET/CT in the initial staging and bone marrow involvement of patients with multiple myeloma.

Authors:  Sait Sager; Nurhan Ergül; Hediye Ciftci; Güven Cetin; Sebnem Izmir Güner; Teyfik Fikret Cermik
Journal:  Skeletal Radiol       Date:  2011-01-13       Impact factor: 2.199

2.  Proliferation and Angiogenesis Using Immunohistochemistry in Prognosticating Multiple Myeloma.

Authors:  Sarah Grace Priyadarshini; Debdatta Basu; Rakhee Kar; T K Dutta
Journal:  Indian J Hematol Blood Transfus       Date:  2016-01-19       Impact factor: 0.900

3.  Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.

Authors:  Sanja Stifter; Emina Babarović; Toni Valković; Irena Seili-Bekafigo; Christophe Stemberger; Antica Nacinović; Ksenija Lucin; Nives Jonjić
Journal:  Diagn Pathol       Date:  2010-05-18       Impact factor: 2.644

4.  Pancytopenia in Multiple Myeloma- An Enigma: Our Experience from Tertiary Care Hospital.

Authors:  Hanaganahalli B Sridevi; Sharada Rai; Pooja K Suresh; Meludurgamutt S Somesh; Jessica Minal
Journal:  J Clin Diagn Res       Date:  2015-11-01

5.  Rapid in-situ hybridization and immunohistochemistry: a pilot comparative study of two rapid diagnostic techniques for establishing monoclonality in plasma cell dyscrasias.

Authors:  Arijit Sen; Divya Gupta; Rajat Jagani
Journal:  Med J Armed Forces India       Date:  2019-04-05

6.  Role of CD138, CD56, and light chain immunohistochemistry in suspected and diagnosed plasma cell myeloma: A prospective study.

Authors:  Jasmita Dass; Sudheer Arava; Pravas Chandra Mishra; Amit Kumar Dinda; Hara Prasad Pati
Journal:  South Asian J Cancer       Date:  2019 Jan-Mar

7.  The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors.

Authors:  Barry Paul; Yue Zhao; Gavin Loitsch; Daniel Feinberg; Parker Mathews; Ian Barak; Megan Dupuis; Zhiguo Li; Lindsay Rein; Endi Wang; Yubin Kang
Journal:  Cancer Med       Date:  2020-07-06       Impact factor: 4.452

8.  Expression of myeloid antigen in neoplastic plasma cells is related to adverse prognosis in patients with multiple myeloma.

Authors:  Hyoeun Shim; Joo Hee Ha; Hyewon Lee; Ji Yeon Sohn; Hyun Ju Kim; Hyeon-Seok Eom; Sun-Young Kong
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.